Founded 1969


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 49
Average round size
The average size of a deal this fund participated in
Portfolio companies 32
Rounds per year 0.62
Lead investments 11
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 5

Areas of investment

  • E-Commerce
  • Fashion
  • Financial Services
  • Internet
  • Marketplace

Eurazeo is the famous VC, which was founded in 1969. The venture was found in Europe in France. The main department of described VC is located in the Paris.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Eurazeo, startups are often financed by Idinvest Partners, Condu00e9 Nast, Alven Capital. The meaningful sponsors for the fund in investment in the same round are Bpifrance, Idinvest Partners, Vitruvian Partners. In the next rounds fund is usually obtained by Bpifrance, Weber Investissement, Vitruvian Partners.

The overall number of key employees were 42.

The top amount of exits for fund were in 2018. The important activity for fund was in 2019. The typical startup value when the investment from Eurazeo is 500 millions - 1 billion dollars. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Eurazeo performs on 12 percentage points less the average number of lead investments. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies.

Among the most popular fund investment industries, there are E-Commerce, Consumer Goods. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Farfetch, Doctolib, Pat McGrath Labs. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - France.

Read more

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Late Stage Venture
650M01 Jun 2021


Sales Automation
Late Stage Venture
500M25 May 2021 France, Paris

Back Market

Consumer Electronics
Late Stage Venture
335M18 May 2021 France, Paris


Cloud Computing
Enterprise Software
Late Stage Venture
800M28 Apr 2021 Netherlands, Amsterdam

Vestiaire Collective

E-Commerce Platforms
Social Shopping
Late Stage Venture
208M01 Mar 2021 France, Paris


Financial Services
Private Equity
180M19 Jan 2021 United Kingdom, London


Financial Services
Venture - Series Unknown
100M11 Dec 2020 Sweden, Stockholm

Dewey’s Bakery

Food and Beverage
Private Equity
25M01 Oct 2020
United States, Winston-Salem

Thought Machine

Enterprise Software
Financial Services
Early Stage Venture
125M28 Jul 2020 United Kingdom, Westminster
Sorare Raises $680M in Series B Funding; Valued at $4.3 Billion
– Sorare is a Paris, France, NFT-based fantasy football platform. – The company raised $680m in Series B funding. – The round was led by Softbank with participation from Atomico, Bessemer Ventures, D1 Capital, Eurazeo, IVP, Liontree and existing investors Benchmark, Accel and Headline, as well as football players Gerard Piqué, Antoine Griezmann, Rio Ferdinand and César Azpilicueta. – The new investment will be used to accelerate growth within football while also replicating its model in other sports, expan... Read more
Amolyt Pharma Raises $80M in Series B Financing
– Amolyt Pharma from Lyon develops therapeutic peptides for rare endocrine and related diseases. – The company closed an $80m Series B round. – The round was co-led by Sectoral Asset Management and Andera Partners, with participation from ATEM Capital, LSP, Novo Holdings (Novo Ventures), Kurma Partners, Mass General Brigham Ventures, Innobio 2 managed by Bpifrance, Orbimed, Pontifax, Eurazeo, Sham Innovation Santé/Turenne Capital and Credit Agricole Creation. – The company plans to use the proceeds from th... Read more


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Eurazeo?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: